Waldenstrom's Macroglobulinemia Treatment Market, Global Outlook and Forecast 2022-2028

July 2022 | 66 pages | ID: W765E97BC538EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Waldenstrom's Macroglobulinemia Treatment in Global, including the following market information:

Global Waldenstrom's Macroglobulinemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Waldenstrom's Macroglobulinemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bendamustine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Waldenstrom's Macroglobulinemia Treatment include Johnson & Johnson Services, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, BeiGene, AstraZeneca, Cellectar Biosciences, Inc, TG Therapeutics, Curis, Inc. and X4 Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Waldenstrom's Macroglobulinemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Waldenstrom's Macroglobulinemia Treatment Market, by Treatment Method, 2017-2022, 2023-2028 ($ millions)

Global Waldenstrom's Macroglobulinemia Treatment Market Segment Percentages, by Treatment Method, 2021 (%)

• Bendamustine
• Rituximab
• BTK Inhibitors

Global Waldenstrom's Macroglobulinemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Waldenstrom's Macroglobulinemia Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Waldenstrom's Macroglobulinemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Waldenstrom's Macroglobulinemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Waldenstrom's Macroglobulinemia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Waldenstrom's Macroglobulinemia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson Services, Inc.
• AbbVie Inc.
• Takeda Pharmaceutical Company Limited
• BeiGene
• AstraZeneca
• Cellectar Biosciences, Inc
• TG Therapeutics
• Curis, Inc.
• X4 Pharmaceuticals
• InnoCare
• Ascentage Pharma
• Pharmacyclics LLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Waldenstrom's Macroglobulinemia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Treatment Method
  1.2.2 Market by Application
1.3 Global Waldenstrom's Macroglobulinemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL WALDENSTROM'S MACROGLOBULINEMIA TREATMENT OVERALL MARKET SIZE

2.1 Global Waldenstrom's Macroglobulinemia Treatment Market Size: 2021 VS 2028
2.2 Global Waldenstrom's Macroglobulinemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Waldenstrom's Macroglobulinemia Treatment Players in Global Market
3.2 Top Global Waldenstrom's Macroglobulinemia Treatment Companies Ranked by Revenue
3.3 Global Waldenstrom's Macroglobulinemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Waldenstrom's Macroglobulinemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Waldenstrom's Macroglobulinemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Waldenstrom's Macroglobulinemia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Waldenstrom's Macroglobulinemia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Waldenstrom's Macroglobulinemia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Treatment Method - Global Waldenstrom's Macroglobulinemia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Bendamustine
  4.1.3 Rituximab
  4.1.4 BTK Inhibitors
4.2 By Treatment Method - Global Waldenstrom's Macroglobulinemia Treatment Revenue & Forecasts
  4.2.1 By Treatment Method - Global Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2022
  4.2.2 By Treatment Method - Global Waldenstrom's Macroglobulinemia Treatment Revenue, 2023-2028
  4.2.3 By Treatment Method - Global Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Waldenstrom's Macroglobulinemia Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Waldenstrom's Macroglobulinemia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Waldenstrom's Macroglobulinemia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Waldenstrom's Macroglobulinemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Waldenstrom's Macroglobulinemia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Waldenstrom's Macroglobulinemia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2028
  6.3.2 US Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.3.3 Canada Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.3.4 Mexico Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2028
  6.4.2 Germany Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.4.3 France Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.4.4 U.K. Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.4.5 Italy Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.4.6 Russia Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.4.8 Benelux Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2028
  6.5.2 China Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.5.3 Japan Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.5.4 South Korea Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.5.6 India Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2028
  6.6.2 Brazil Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.6.3 Argentina Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2028
  6.7.2 Turkey Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.7.3 Israel Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028
  6.7.5 UAE Waldenstrom's Macroglobulinemia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson Services, Inc.
  7.1.1 Johnson & Johnson Services, Inc. Corporate Summary
  7.1.2 Johnson & Johnson Services, Inc. Business Overview
  7.1.3 Johnson & Johnson Services, Inc. Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.1.4 Johnson & Johnson Services, Inc. Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Services, Inc. Key News
7.2 AbbVie Inc.
  7.2.1 AbbVie Inc. Corporate Summary
  7.2.2 AbbVie Inc. Business Overview
  7.2.3 AbbVie Inc. Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.2.4 AbbVie Inc. Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.2.5 AbbVie Inc. Key News
7.3 Takeda Pharmaceutical Company Limited
  7.3.1 Takeda Pharmaceutical Company Limited Corporate Summary
  7.3.2 Takeda Pharmaceutical Company Limited Business Overview
  7.3.3 Takeda Pharmaceutical Company Limited Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.3.4 Takeda Pharmaceutical Company Limited Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Takeda Pharmaceutical Company Limited Key News
7.4 BeiGene
  7.4.1 BeiGene Corporate Summary
  7.4.2 BeiGene Business Overview
  7.4.3 BeiGene Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.4.4 BeiGene Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.4.5 BeiGene Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.5.4 AstraZeneca Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Cellectar Biosciences, Inc
  7.6.1 Cellectar Biosciences, Inc Corporate Summary
  7.6.2 Cellectar Biosciences, Inc Business Overview
  7.6.3 Cellectar Biosciences, Inc Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.6.4 Cellectar Biosciences, Inc Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.6.5 Cellectar Biosciences, Inc Key News
7.7 TG Therapeutics
  7.7.1 TG Therapeutics Corporate Summary
  7.7.2 TG Therapeutics Business Overview
  7.7.3 TG Therapeutics Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.7.4 TG Therapeutics Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.7.5 TG Therapeutics Key News
7.8 Curis, Inc.
  7.8.1 Curis, Inc. Corporate Summary
  7.8.2 Curis, Inc. Business Overview
  7.8.3 Curis, Inc. Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.8.4 Curis, Inc. Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.8.5 Curis, Inc. Key News
7.9 X4 Pharmaceuticals
  7.9.1 X4 Pharmaceuticals Corporate Summary
  7.9.2 X4 Pharmaceuticals Business Overview
  7.9.3 X4 Pharmaceuticals Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.9.4 X4 Pharmaceuticals Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.9.5 X4 Pharmaceuticals Key News
7.10 InnoCare
  7.10.1 InnoCare Corporate Summary
  7.10.2 InnoCare Business Overview
  7.10.3 InnoCare Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.10.4 InnoCare Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.10.5 InnoCare Key News
7.11 Ascentage Pharma
  7.11.1 Ascentage Pharma Corporate Summary
  7.11.2 Ascentage Pharma Business Overview
  7.11.3 Ascentage Pharma Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.11.4 Ascentage Pharma Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.11.5 Ascentage Pharma Key News
7.12 Pharmacyclics LLC
  7.12.1 Pharmacyclics LLC Corporate Summary
  7.12.2 Pharmacyclics LLC Business Overview
  7.12.3 Pharmacyclics LLC Waldenstrom's Macroglobulinemia Treatment Major Product Offerings
  7.12.4 Pharmacyclics LLC Waldenstrom's Macroglobulinemia Treatment Revenue in Global Market (2017-2022)
  7.12.5 Pharmacyclics LLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Waldenstrom's Macroglobulinemia Treatment Market Opportunities & Trends in Global Market
Table 2. Waldenstrom's Macroglobulinemia Treatment Market Drivers in Global Market
Table 3. Waldenstrom's Macroglobulinemia Treatment Market Restraints in Global Market
Table 4. Key Players of Waldenstrom's Macroglobulinemia Treatment in Global Market
Table 5. Top Waldenstrom's Macroglobulinemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Waldenstrom's Macroglobulinemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Waldenstrom's Macroglobulinemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Waldenstrom's Macroglobulinemia Treatment Product Type
Table 9. List of Global Tier 1 Waldenstrom's Macroglobulinemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Waldenstrom's Macroglobulinemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Treatment Method – Global Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Treatment Method - Waldenstrom's Macroglobulinemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Treatment Method - Waldenstrom's Macroglobulinemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Waldenstrom's Macroglobulinemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Waldenstrom's Macroglobulinemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Services, Inc. Corporate Summary
Table 31. Johnson & Johnson Services, Inc. Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 32. Johnson & Johnson Services, Inc. Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AbbVie Inc. Corporate Summary
Table 34. AbbVie Inc. Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 35. AbbVie Inc. Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Pharmaceutical Company Limited Corporate Summary
Table 37. Takeda Pharmaceutical Company Limited Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 38. Takeda Pharmaceutical Company Limited Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. BeiGene Corporate Summary
Table 40. BeiGene Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 41. BeiGene Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 44. AstraZeneca Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Cellectar Biosciences, Inc Corporate Summary
Table 46. Cellectar Biosciences, Inc Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 47. Cellectar Biosciences, Inc Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. TG Therapeutics Corporate Summary
Table 49. TG Therapeutics Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 50. TG Therapeutics Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Curis, Inc. Corporate Summary
Table 52. Curis, Inc. Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 53. Curis, Inc. Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 54. X4 Pharmaceuticals Corporate Summary
Table 55. X4 Pharmaceuticals Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 56. X4 Pharmaceuticals Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 57. InnoCare Corporate Summary
Table 58. InnoCare Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 59. InnoCare Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Ascentage Pharma Corporate Summary
Table 61. Ascentage Pharma Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 62. Ascentage Pharma Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Pharmacyclics LLC Corporate Summary
Table 64. Pharmacyclics LLC Waldenstrom's Macroglobulinemia Treatment Product Offerings
Table 65. Pharmacyclics LLC Waldenstrom's Macroglobulinemia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Waldenstrom's Macroglobulinemia Treatment Segment by Treatment Method in 2021
Figure 2. Waldenstrom's Macroglobulinemia Treatment Segment by Application in 2021
Figure 3. Global Waldenstrom's Macroglobulinemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Waldenstrom's Macroglobulinemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Waldenstrom's Macroglobulinemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Waldenstrom's Macroglobulinemia Treatment Revenue in 2021
Figure 8. By Treatment Method - Global Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 12. US Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 24. China Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Waldenstrom's Macroglobulinemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Waldenstrom's Macroglobulinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Services, Inc. Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbbVie Inc. Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Pharmaceutical Company Limited Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BeiGene Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cellectar Biosciences, Inc Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. TG Therapeutics Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Curis, Inc. Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. X4 Pharmaceuticals Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. InnoCare Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ascentage Pharma Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pharmacyclics LLC Waldenstrom's Macroglobulinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)